跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG - HSA Drug Approval Details
Approvals
/
HSA
/
VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG
Approved
THERAPEUTIC
VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG
Xellia Pharmaceuticals ApS
🇸🇬 Health Sciences Authority
Approval Date
Aug 22, 2016
Approval ID
6375ba4549a4924e
Company
Xellia Pharmaceuticals ApS
Type
Therapeutic
Approval Details
Approval Id
6375ba4549a4924e
Drug Name
VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG
Product Name
VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG
Approval Number
SIN15070P
Approval Date
2016-08-22
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01XA01
Atc Item Name
vancomycin
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Company Detail Path
/organization/fresenius-kabi-singapore-pte-ltd
Active Ingredients
Vancomycin hydrochloride 512mg eqv Vancomycin
500mg/vial
Vancomycin hydrochloride 512mg eqv Vancomycin
500mg/vial
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 22, 2016
Approval ID
6375ba4549a4924e
Type
Therapeutic
Back to HSA Approvals